BlueWillow Biologics
Latest round
- Series A
Last raised
- May 2018
Total raised
- $63M
Investors
- 5
About BlueWillow Biologics
BlueWillow Biologics Inc.Founded in 2000 and headquartered in Ann Arbor, US, BlueWillow Biologics specializes in vaccine development.BlueWillow Biologics specializes in vaccine development through its core technology, the NanoVax® platform. This intranasal adjuvant and antigen delivery system addresses the prevention and treatment of infectious diseases, targeting pathogens such as H5N1, seasonal and pandemic influenza, tuberculosis, COVID-19, respiratory syncytial virus (RSV), and herpes simplex virus. The NanoVax® platform is compatible with various antigens, enabling a comprehensive immune response.BlueWillow Biologics generates revenue through collaborative partnerships and clinical trial engagements aimed at developing its vaccine candidates. The company collaborates with pharmaceutical firms, government agencies, and healthcare organizations to advance its intranasal vaccine technology, structured around research and development agreements that may include milestone payments. The flagship product, NanoVax®, represents a significant component of the company's portfolio, with revenue potential linked to successful product development and commercialization. The company aims to expand its market presence in both North America and Europe by enhancing its partnerships with healthcare providers and institutions. Specific timelines for product releases and geographic expansions will be determined as development progresses and market conditions evolve.
Who invested in BlueWillow Biologics
5 investors across 5 rounds
See all investors in BlueWillow Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BlueWillow Biologics
Who invested in BlueWillow Biologics?
BlueWillow Biologics has 5 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BlueWillow Biologics raised?
BlueWillow Biologics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did BlueWillow Biologics last raise money?
BlueWillow Biologics's most recent round on record is a Series A, in May 2018.
What does BlueWillow Biologics do?
BlueWillow Biologics is a biotechnology company.
Where is BlueWillow Biologics headquartered?
BlueWillow Biologics is headquartered in Ann Arbor, US.
Which VCs invest in companies like BlueWillow Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BlueWillow Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like BlueWillow Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.